Colette (Coco) is an Associate Professor in the UC Berkeley School of Public Health and Director of the UC Berkeley–UCSF Joint Medical Program. She holds academic positions at both the Berkeley and San Francisco campuses of the University of California. She is a pediatrician specialized in adolescent medicine. Her research consistently focuses on the social determinants of health of our society’s most disadvantaged youth and on structural interventions to positively impact on their health while employing a community collaborative and youth-engaged approach. She is the co-founder and co-director of i4Y (Innovations for Youth) and the faculty lead for the Ending

Gato Ian Gourley is the Center for Vulnerable Populations (CVP) Division Manager. He has worked with CVP for over 7 years. He is very excited to be supporting the newly created Division of the Center for Vulnerable Populations at ZSFG in order to further the CVP’s mission and continue its growth with the Benioff Homelessness and Housing Initiative. He is extremely passionate about the CVP’s mission and is deeply committed to pursuing social justice and health equity. He has an MSc in Development Management from the London School of Economics and Political Science and a BA in Sociology from the

Dr. Margaret Handley is a public heath-trained epidemiologist in the Departments of Epidemiology and Biostatistics and Medicine. She is core faculty at the Center for Vulnerable Populations and at the Benioff Housing and Homelessness Initiative. Dr. Handley’s research focuses on bridging the fields of primary care, public health, and health communication for improving health outcomes and equity. She co-directs the UCSF PRISE Center, Partnerships for Research in Implementation Science for Equity) which focuses on applying implementation science methods to meet the challenges of inequitable health and health care. At BHHI she is one of the Principal Investigators along with Drs

Margot Kushel, MD, is Professor of Medicine at UCSF, Division Chief of the Center for Vulnerable Populations, and Director of the Benioff Homelessness and Housing Initiative at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG). Her research focuses on reducing the burden of homelessness on health through examining efforts to prevent and end homelessness and mitigating its effects on health care outcomes. Margot is a primary care physician at ZSFG’s Richard H. Fine People's Clinic. A leading homelessness researcher, her research has been funded by the NIH, government, and foundations. Margot is quoted frequently in the press. She provides

Dr. Vijayaraghavan is a practicing general internist at the San Francisco General Hospital and a researcher in tobacco control with a focus on populations experiencing homelessness. Dr. Vijayaraghavan's intervention research stems from collaborations with community organizations. As PI of two grants (22XT-0020, 25CP-0002) from the Tobacco Related Disease Research Program, she collaborated with homeless shelters and supportive housing programs to implement interventions to increase access to cessation services and smoke-free policies among homeless clients. As co-investigator (PI Satterfield, DA034253-04) on an implementation and dissemination grant on a randomized controlled trial of computer-facilitated delivery of 5As for smoking cessation, she worked

Dr. Morris’ professional activities are grounded in engaging diverse partners in the development of evidence-based policy change to reduce social inequalities and improve health among underserved communities. As an Associate Professor, Dr. Morris’ research focuses on applying epidemiological methods to study the impact of individual, social, and structural factors on disease transmission within marginalized populations. In particular, her work has focused on using qualitative and quantitative methods to examine social determinants of health within people who use drugs, including HIV and hepatitis C virus (HCV) infection, worldwide. Internationally Dr. Morris has collaborated with researchers to carry out HIV and HCV